InvestorsHub Logo
Followers 5427
Posts 149175
Boards Moderated 2
Alias Born 02/17/2010

Re: SOUTHGAS post# 8420

Saturday, 01/21/2012 3:21:35 PM

Saturday, January 21, 2012 3:21:35 PM

Post# of 75926
SNDY Goes Google. Apple Application is HUGE way to expand further. Very briliant. This company has so much going for it in which the PPS should be much much higher imo. Looks like we will see a huge breakout like last year to .02+ cents soon imo.

Solos Endoscopy Goes Google
Print
Alert
Solos Endoscopy (PC) (USOTC:SNDY)
Historical Stock Chart
3 Months : October 2011 to January 2012


Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company is going Google. Solos Endoscopy, by switching to Google Apps, will be able to expand and improve collaboration with its vendors and clients as well as help its employees communicate efficiently. Solos will now have the capability to communicate and access its content from any Internet connected computer or mobile device, helping the Company reduce its IT costs.

In addition to Google Apps, Solos Endoscopy will now use Constant Contact's effective and affordable online marketing tools to win customers and build strong, lasting relationships. These online marketing tools are specially designed to help small businesses and organizations drive participation and strengthen relationships.

As part of its Social Media Campaign, Solos Endoscopy plans on using the following Constant Contact tools:

- Email Marketing for quickly creating professional-looking emails, managing contact lists, measuring campaign results, and reviewing new list members;

- Social Media Marketing for turning fans, friends, and followers into customers. Harnessing digital word of mouth from Facebook, retweeting offers on Twitter, or posting a review on Yelp keeps the conversation going and generates a powerful buzz for Solos Endoscopy;

- Event Marketing for efficiently promoting and managing registrations and RSVPs for meetings, functions, seminars, and events;

- Online Survey for gathering feedback that helps meet Solos customer needs, generate new ideas, and help grow a business or organization.

"We are committed to using the 21st Century tools to effectively market our product line to Hospitals across the Country and around the World," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Constant Contact, Inc.

Constant Contact is revolutionizing the success formula for small organizations through affordable, easy-to-use Engagement Marketing™ tools that help create and grow customer relationships. More than 450,000 small businesses, nonprofits, and associations worldwide rely on Constant Contact to drive ongoing customer dialogs through email marketing, social media marketing, event marketing, and online surveys.

Constant Contact and the Constant Contact Logo are registered trademarks of Constant Contact, Inc. All Constant Contact product names and other brand names mentioned herein are trademarks or registered trademarks of Constant Contact, Inc. All other company and product names may be trademarks or service marks of their respective owners.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

CONTACT: Amanda Segersten rsegersten@solosendoscopy.com

SOURCE Solos Endoscopy, Inc.